InsiderTrades

Form 4 for ELAN Elanco Animal Health Inc

Accepted 2026-08-10 16:14:59 ET · period of report 2026-08-07 · accession 0001724169-26-000037 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-08-10 16:14 2026-08-07 ELAN VanHimbergen Robert M EVP, CFO P - Purchase $23.08 +4,200 137.5K +3% +$96.9K
D 2026-08-10 16:14 2026-08-07 ELAN VanHimbergen Robert M EVP, CFO A - Grant $22.12 +8.91 133.60 +7% +$197.02

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-07 P A 4,200 $23.08 137,516 D — — (F1) Reflects the weighted average price of 4,200 shares of common stock of Elanco Animal Health Inc. purchased by the reporting person in multiple transactions on August 7, 2026 with purchase prices ranging from $23.01 to $23.09 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
2 Derivative Deferred Stock Units 2026-08-07 A A 8.91 $22.12 133.60 D — · — to — 8.91 Common Stock (F2) Each deferred stock unit represents the right to receive one share of Company common stock or the cash equivalent. (F3) Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan. (F3) Deferred stock units settle in cash or shares of Company common stock following termination of employment or during a specified future year in accordance with Executive Deferral and Stock Match Plan.